期刊文献+

ERK信号通路:病毒感染依赖的宿主机制及潜在抗病毒靶标 被引量:5

ERK signal cascade:the host cell′s mechinery for viral reproduction and its implication as the potential anti-viral target
原文传递
导出
摘要 细胞外调节蛋白激酶(extracellular regulated protein kinases,ERK)通路是20世纪80年代初发现的丝裂原活化蛋白激酶(mitogen-activatedprotein kinase,MAPK)家族中的一个重要成员,由Raf、MEK(MAPK/ERK kinase)、ERK三个不同层级的激酶蛋白组成,并依次顺序激活。 Virus utilizes components of the host cell′s metabolic machinery for its reproduction.Activation of the extra-cellular regulated protein kinases(ERK)signaling cascade has been shown to be one of the important machineries in response to infections of a variety of viruses.Therefore,blockage of this cellular pathway may finally bring completely novel concepts of antiviral therapy.In this review,the critical role and important impact of ERK pathway in viral infection,e.g.viral replication and its pathogenesis were summarized;and the current progress in cancer therapy and the potential application of small molecular inhibitors specific to Raf-MEK-ERK signaling were discussed as well.
作者 彭宜红
出处 《中国病毒病杂志》 CAS 2012年第6期404-408,共5页 Chinese Journal of Viral Diseases
基金 国家高技术研究发展计划(863计划)资助项目(2007AA02Z317) 国家自然科学基金(30470084 21172012/B020601)
关键词 ERK信号通路 病毒 小分子抑制剂 ERK Viral infection Small molecule inhibitor
  • 相关文献

参考文献40

  • 1Oka H, Chatani Y, Hoshino R, et al. Constitutive activa tion of mitogen-activated protein (MAP) kinases in human renal cell carcinoma [J]. Cancer Res, 1995, 55 (18): 4182-4187.
  • 2Hoshino R, Chatani Y, Yamori T, et al. Constitutive acti- vation of the 41 /43-kDa mitogen-activated protein kinase signaling pathway in human tumors [J]. Oncogene, 1999, 18 (3) : 813-822.
  • 3Kohno M, Pouyssegur J. Targeting the ERK signaling pathway in cancer therapy [J]. Ann Med, 2006, 38 (3): 200 -211.
  • 4Sebolt Leopold JS, Herrera R. Targeting the mitogen aeti vated protein kinase cascade to treat cancer [J]. Nat Rev Cancer, 2004, 4 (12): 937-947.
  • 5Santarpia L, Lippman SM, E1 Naggar AK. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy [J]. Expert OpinTher Targets, 2012, 16 (1): 103-119.
  • 6Chapman MS, Miner JN. Novel mitogen activated protein kinase kinase inhibitors [J]. Expert Opin Investig Drugs, 2011, 20 (2):209-220.
  • 7Stein MN, Flaherty KT. CCR drug updates: sorafenib and sunitinib in renal cell carcinoma [J]. Clin Cancer Res, 2007, 13 (13): 3765-3770.
  • 8Smith CC, Luo JH, Hunter JC, et al. The transmembrane domain of the large subunit of HSV-2 ribonucleotide reduc tase (ICP10) is required for protein kinase activity and transformation-related signaling pathways that result in ras activation[J]. Virology, 1994, 200 (2): 598- 612.
  • 9Smith CC, Nelson J, Aurelian L, et al. Ras GAP binding and phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/MEK/MAPK mitogenic pathway are required for timely onset of virus growth [J]. J Virol, 2000, 74 (22): 10417-10429.
  • 10Jabado N, Pallier A, Jauliac S, etal. gpl60 of HIV or an- ti CD4 monoclonal antibody ligation of CD4 induces inhibition of JNK and ERK-2 activities in human peripheral CD4+ T lymphocytes[J]. Eur J Immunol, 1997, 27 (2): 397- 404.

共引文献20

同被引文献108

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部